BioNTech SE (BNTX)

Every figure this model derived for BNTX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 175,100,000 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2025-12-31
cash 14,877,200,000 CashAndCashEquivalents 2025-12-31
current assets 16,146,600,000 CurrentAssets 2025-12-31
current liabilities 2,142,300,000 CurrentLiabilities 2025-12-31
equity 19,224,200,000 Equity 2025-12-31
interest expense 14,200,000 InterestExpense 2025-12-31
ocf 456,000,000 CashFlowsFromUsedInOperatingActivities 2025-12-31
revenue 2,869,900,000 RevenueFromContractsWithCustomers 2025-12-31
sbc 106,300,000 ExpenseFromSharebasedPaymentTransactionsWithEmployees 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up BNTX on one particular measure came for.

RatioValue
cash operating margin-43.26
current ratio7.54
current ratio reported7.54
ev owner earnings170.96
ev sales10.4
fcf margin9.79
interest cover-98.94
operating margin-48.95
owner earnings margin6.08
revenue growth4.32
revenue growth per share4.32
roic-24.25
rule of 40-44.63
sbc pct revenue3.7

What to be careful about

What this model itself distrusts about BNTX's figures. Written by the derivation as it ran, not added afterwards.